RECRUITING

Immunogenicity of HPV Vaccine in Transplant Recipients.

Description

To measure levels of HPV antibodies in post-solid-organ transplant recipients who have gotten the HPV9 vaccine.

Conditions

Chronic Kidney DiseasesKidney Transplant
Talk to us

Related Conditions:

Chronic Kidney DiseasesKidney Transplant

Study Overview

On this page

Study Details

Study overview

To measure levels of HPV antibodies in post-solid-organ transplant recipients who have gotten the HPV9 vaccine.

Prospective Analysis of Immunogenicity of the Nonavalent Human Papillomavirus Vaccination (GARDASIL 9) in Patients Post Solid Organ Transplant

Immunogenicity of HPV Vaccine in Transplant Recipients.

Condition
Chronic Kidney Diseases
Intervention / Treatment

-

Contacts and Locations

Milwaukee

Froedtert Lutheran Memorial Hospital, Milwaukee, Wisconsin, United States, 53226

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • 1. Patient between the age of 18 and 45 years
  • 2. Patient is at least 6 months post-solid-organ transplant and has not received GARDASIL 9.
  • 3. Patient who can participate in their health care and sign informed consent.
  • 4. Patient may have had bivalent or quadrivalent HPV vaccination previously.
  • 5. Living or deceased donor transplant patient is eligible.
  • 6. Contraindication: Hypersensitivity, including severe allergic reactions to yeast (a vaccine component), or after a previous dose of GARDASIL 9 or GARDASIL.
  • 7. Patient had completed vaccination series with a nonavalent HPV vaccine (e.g., GARDASIL 9) in the past
  • 8. Patient with a diagnosis of HIV.
  • 9. Patient that endorses being currently pregnant.

Ages Eligible for Study

18 Years to 45 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Medical College of Wisconsin,

Denise Uyar, MD, PRINCIPAL_INVESTIGATOR, Medical College of Wisconsin/ Froedtert Hospital

Study Record Dates

2035-12-31